Terragen launches first international feedlot trial for its Probiotic™ for Ruminants in Canada
Terragen has taken an important step in expanding its global footprint, announcing the first international research trialof its Probiotic™ for Ruminants (TPR) — a live microbial supplement designed to support animal health and performance.
The two-phase Canadian feedlot trial, conducted in partnership with the Agriculture and Agri-Food Canada (AAFC), the University of Calgary, and the Beef Cattle Research Council, will evaluate TPR’s effect on cattle growth performance, carcass quality, and gut-immune function under North American production conditions.
AAFC’s Professor Trevor Alexander said the study aligns with their broader research focus on bovine respiratory disease (BRD) and animal health.
“We’re excited to explore how probiotics influence gut and respiratory health in feedlot cattle,” he said.
Phase one focuses on digestion, microbiota, and immunity across a 60-day period, while phase two extends to 300 days, assessing long-term productivity, health outcomes and carcass quality.
Terragen COO and veterinarian, Dr Joss West, said the project underscores Terragen’s commitment to independent research and data-driven innovation.
“This collaboration allows us to validate the performance of TPR in a major global beef market,” he said.
“It’s a crucial step toward demonstrating the consistent value of probiotic technology across diverse production systems.”
The trial builds on Terragen’s proven results in Australia, including a 2024 feedlot trial at Charles Sturt University showing improved average daily gain, feed efficiency, and carcass value in Angus steers fed TPR.
